A randomised, double-blinded, placebo-controlled, trial to determine the individual response in bone turnover markers to lasofoxifene therapy
Author:
Publisher
Elsevier BV
Subject
Histology,Physiology,Endocrinology, Diabetes and Metabolism
Reference21 articles.
1. Lasofoxifene: a third-generation selective estrogenreceptor modulator for the prevention and treatment of osteoporosis;Gennari;Expert Opin. Investig. Drugs,2006
2. Lasofoxifene: a new type of selective estrogen receptor modulator for the treatment of osteoporosis;Gennari;Drugs Today (Barc),2006
3. Lasofoxifene (CP-336,156) protects against the age-related changes in bone mass, bone strength, and total serum cholesterol in intact aged male rats;Ke;J Bone Miner. Res.,2001
4. Long-term treatment of lasofoxifene preserves bone mass and bone strength and does not adversely affect the uterus in ovariectomized rats;Ke;Endocrinology,2004
5. Prevention of bone loss in postmenopausal women treated with lasofoxifene compared with raloxifene;McClung;Menopause,2006
Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Effectiveness and Usefulness of Bone Turnover Marker in Osteoporosis Patients: A Multicenter Study in Korea;Journal of Bone Metabolism;2023-11-30
2. Zoledronic Acid Ameliorates the Bone Turnover Activity and Periprosthetic Bone Preservation in Cementless Total Hip Arthroplasty;Pharmaceuticals;2022-03-30
3. Pharmacological Therapies for Osteoporosis: A Bayesian Network Meta-Analysis;Medical Science Monitor;2022-02-25
4. Effect of selenium supplementation on musculoskeletal health in older women: a randomised, double-blind, placebo-controlled trial;The Lancet Healthy Longevity;2021-04
5. Analytical considerations and plans to standardize or harmonize assays for the reference bone turnover markers PINP and β-CTX in blood;Clinica Chimica Acta;2021-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3